Home / Inspections / 1014636

FDA Inspection 1014636 — HP Halden Pharma AS

HP Halden Pharma AS — FEI 3002608066

The FDA completed an inspection of HP Halden Pharma AS on May 26, 2017 in Halden. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 26, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Halden (Norway)

Facility

Other inspections at this facility

  • 1205610 (VAI Wed May 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1101303 (VAI Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 931958 (VAI Fri Jun 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 863615 (VAI Fri Dec 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 797565 (VAI Thu Aug 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources